Le Lézard
Classified in: Health

Dr. Ioannis Skaribas, M.D., FASA, DABA Performs the First Abbott Proclaim XRtm Spinal Cord Stimulator Procedure in Houston, TX


HOUSTON, Jan. 27, 2020 /PRNewswire/ -- Dr. Ioannis Skaribas, a leader in Interventional Pain Management, is the first physician in his region to perform a spinal cord stimulator implant with the new Abbott Proclaim XRtm neurostimulation system.

This device was FDA approved in September earlier this year. The Proclaim XRtm system offers a low dose of Abbott's BurstDRtm stimulation waveform. The stimulation mimics natural patterns found in the brain, based off of scientific research. Low doses of electrical pulses change the pain signals as they move from the spinal cord to the brain. Because it is a low dose, the battery life is extended. The Proclaim XRtm neurostimulation system allows patients to have pain relief without recharging the batteries for up to 10 years.

Dr. Skaribas is Double-Board certified in Anesthesiology and Pain Medicine by the American Board of Anesthesiology, a Fellow of the American Society of Anesthesiologists, and completed his Internship, Residency, as well as a one-year intenventional Fellowship at the prestigious Baylor College of Medicine in Houston, Texas. He currently serves as the medical director and CEO of Expert Pain Care, a center of excellence for advanced interventional Pain Management practices. Dr. Skaribas has published in numerous textbook and medical journal manuscripts, and is an active member of local, national, and international professional medical societies.

Dr. Skaribas is honored to work with Abbott on performing these groundbreaking procedures with the latest technology in pain management.

Media contact:
Ioannis Skaribas
[email protected] 
(832) 862-PAIN

SOURCE Dr. Ioannis Skaribas


These press releases may also interest you

at 11:15
Variantyx, a leader in molecular diagnostics, announced today that it has secured an additional $36 million in funding from its portfolio of investors which includes Peregrine Ventures, Pitango HealthTech, New Era Capital Partners and Bosch Ventures....

at 11:03
The heart of Vajra Coffee's natural decaffeination process lies in its adoption of the Swiss Water® Process, a natural method that removes 99% of caffeine...

at 11:00
United Imaging Healthcare (SSE:688271) has published its 2023 Environment, Social, and Governance (ESG) Report, reaffirming its mission to bring Equal Healthcare for All. This report highlights the company's advancements in corporate responsibility,...

at 11:00
United Imaging Healthcare (SSE:688271), a global leader in manufacturing advanced medical imaging and radiotherapy equipment, has released their 2023 annual report. The report reveals that the company achieved 11.41 billion CNY in revenue in 2023,...

at 10:54
Pierre Fabre Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of OBGEMSAtm (vibegron under the international...

at 10:49
Sustain Exchange LLC is proud to announce a partnership with HearMe, a leading behavioral health peer support platform focused on ensuring healthy lives and promoting well-being. As part of this innovative partnership, SustainAble Exchange will...



News published on and distributed by: